GLP-1 Drugs and the Telehealth Catch

New weight loss drugs like Wegovy and Zepbound are revolutionizing treatment—but getting them covered by insurance? That’s where telehealth companies come in, often hired by employers to cut costs. These firms, now aggressively promoting “wraparound services,” may push patients toward cheaper alternatives—even overriding doctor-prescribed treatments. One patient, David Davis, was forced to try generic sleep apnea meds before accessing Zepbound, ultimately paying out of pocket. While telehealth providers claim they follow guidelines and offer personalized care, critics say their real goal is to get patients off expensive drugs, risking weight regain. It’s a tense balancing act between patient health, employer budgets, and corporate profit—making access frustrating and costly for those who need these meds most. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/4ef23302859dadd5